This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Ferrara JL, Cooke KR, Teshima T . The pathophysiology of acute graft-versus-host disease. Int J Hematol 2003; 78: 181–187.
Higman MA, Vogelsang GB . Chronic graft versus host disease. Br J Haematol 2004; 125: 435–454.
Choi CJ, Nghiem P . Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients. Arch Dermataol 2004; 137: 1202–1206.
Elad S, Or R, Resnick I, Shapira MY . Topical tacrolimus – a novel treatment alternative for cutaneous chronic graft-versus-host disease. Transplant Int 2003; 16: 665–670.
Gupta AK, Chow M . Pimecrolimus: a review. J Eur Acad Dermatol Venereol 2003; 17: 493–503.
Alomar A, Berth-Jones J, Bos JD et al. European Working Group on Atopic Dermatitis. The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol 2004; 151 (Suppl. 70): 3–27.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmook, T., Kraft, J., Benninghoff, B. et al. Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus. Bone Marrow Transplant 36, 87–88 (2005). https://doi.org/10.1038/sj.bmt.1704998
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704998
This article is cited by
-
More than skin deep? Emerging therapies for chronic cutaneous GVHD
Bone Marrow Transplantation (2013)